{"pmid":32371047,"title":"Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic.","text":["Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic.","J Allergy Clin Immunol Pract","Kaye, Leanne","Theye, Benjamin","Smeenk, Ian","Gondalia, Rahul","Barrett, Meredith A","Stempel, David A","32371047"],"journal":"J Allergy Clin Immunol Pract","authors":["Kaye, Leanne","Theye, Benjamin","Smeenk, Ian","Gondalia, Rahul","Barrett, Meredith A","Stempel, David A"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371047","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaip.2020.04.053","topics":["Prevention"],"weight":1,"_version_":1666138496428933120,"score":9.490897,"similar":[{"pmid":32374540,"title":"[Asthma and COPD management during the COVID-19 pandemic].","text":["[Asthma and COPD management during the COVID-19 pandemic].","Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.","Rev Med Suisse","Daccord, Cecile","Touilloux, Brice","Von Garnier, Christophe","32374540"],"abstract":["Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease."],"journal":"Rev Med Suisse","authors":["Daccord, Cecile","Touilloux, Brice","Von Garnier, Christophe"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374540","source":"PubMed","week":"202019|May 04 - May 10","topics":["Prevention"],"weight":1,"_version_":1666138496331415553,"score":76.79244},{"pmid":32324976,"title":"COPD at the Time of COVID-19: A COPD Foundation Perspective.","text":["COPD at the Time of COVID-19: A COPD Foundation Perspective.","Chronic Obstr Pulm Dis","Tal-Singer, Ruth","Crapo, James D","32324976"],"journal":"Chronic Obstr Pulm Dis","authors":["Tal-Singer, Ruth","Crapo, James D"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324976","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.15326/jcopdf.7.2.2020.0149","keywords":["covid-19","chronic obstructive pulmonary disease","copd","coronavirus"],"weight":0,"_version_":1666138493837901824,"score":49.731514},{"pmid":32393594,"title":"Management of patients with COPD during the COVID-19 pandemic.","text":["Management of patients with COPD during the COVID-19 pandemic.","Patients with COPD have an increased risk for severity of COVID-19. Flu-like symptoms with dyspnea may distinguish COVID-19 infection from dyspnea due to a COPD-related exacerbation. Management of COPD with COVID-19 warrants standard-of-care treatment with antimicrobial agents and corticosteroids, though limiting the dose and duration of steroids use may be warranted due to the risk of increased viral shedding. Modalities to treat acute respiratory failure can be used with some caveats. Patients with COPD and COVID-19 infection who treat their illness at home should self-isolate, use nebulizers in ways that avoid viral aerosolization, and frequently disinfect room surfaces.","Cleve Clin J Med","Attaway, Amy","32393594"],"abstract":["Patients with COPD have an increased risk for severity of COVID-19. Flu-like symptoms with dyspnea may distinguish COVID-19 infection from dyspnea due to a COPD-related exacerbation. Management of COPD with COVID-19 warrants standard-of-care treatment with antimicrobial agents and corticosteroids, though limiting the dose and duration of steroids use may be warranted due to the risk of increased viral shedding. Modalities to treat acute respiratory failure can be used with some caveats. Patients with COPD and COVID-19 infection who treat their illness at home should self-isolate, use nebulizers in ways that avoid viral aerosolization, and frequently disinfect room surfaces."],"journal":"Cleve Clin J Med","authors":["Attaway, Amy"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393594","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3949/ccjm.87a.ccc007","topics":["Prevention","Treatment"],"weight":1,"_version_":1666627827892486144,"score":49.129875},{"pmid":32502303,"title":"Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence.","text":["Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence.","The coronavirus disease 2019 (COVID-19) pandemic, caused by a novel coronavirus (SARS-CoV-2), has raised concerns among physicians and their patients with rheumatic diseases (RDs) as the risk of infection was believed to be increased due to altered immune system activity that is typical of RDs and possibly worsened by glucocorticoids and immunosuppressive drugs.[1] An appeal for adherence to therapy was shared among rheumatologists, but special attention should be paid to pregnant women who suffer from RDs.","Int J Gynaecol Obstet","Scioscia, Marco","Praino, Emanuela","Scioscia, Crescenzio","32502303"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic, caused by a novel coronavirus (SARS-CoV-2), has raised concerns among physicians and their patients with rheumatic diseases (RDs) as the risk of infection was believed to be increased due to altered immune system activity that is typical of RDs and possibly worsened by glucocorticoids and immunosuppressive drugs.[1] An appeal for adherence to therapy was shared among rheumatologists, but special attention should be paid to pregnant women who suffer from RDs."],"journal":"Int J Gynaecol Obstet","authors":["Scioscia, Marco","Praino, Emanuela","Scioscia, Crescenzio"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502303","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/ijgo.13255","keywords":["covid-19","pregnancy","rheumatic diseases","therapy"],"topics":["Prevention"],"weight":1,"_version_":1668804508764864512,"score":43.13108},{"pmid":32437598,"title":"The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: Results.","text":["The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: Results.","Chronic Obstr Pulm Dis","Tal-Singer, Ruth","Yawn, Barbara P","Wise, Robert","Thomashow, Byron M","Boyce, Danielle M","32437598"],"journal":"Chronic Obstr Pulm Dis","authors":["Tal-Singer, Ruth","Yawn, Barbara P","Wise, Robert","Thomashow, Byron M","Boyce, Danielle M"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437598","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.15326/jcopdf.7.3.2020.0164","keywords":["covid-19","coronavirus disease 2019","discharge","medical experts","steroids"],"topics":["Prevention"],"weight":1,"_version_":1667521393835638785,"score":43.108597}]}